U.S. names HIV, arthritis drugs for next Medicare price talks ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Gilead Sciences
since
auto-detected in 2 stories
31 days ago
The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis treatment Xeljanz.
11 months ago
Stocks making the biggest moves midday: Boeing, Nvidia, Autodesk, Gilead Sciences and more ○
These are the stocks posting the largest moves in midday trading.
page 1 of 1